Study Targeting Affect Regulation
Completed · Phase 1/Phase 2
Conditions studied: HIV, AIDS, Substance Use Disorders
In brief
This Phase Ib pilot RCT will examine the safety, feasibility, and acceptability of a multi-component intervention to address traumatic stress symptoms among HIV-positive, methamphetamine-using men who have sex with men (MSM). Following a baseline assessment, 56 participants will be randomized to receive either: 1) a 7-session intervention to address traumatic stress related to living with HIV/AIDS; or 2) a 7-session, attention-control condition. Follow-up assessments will be administered at 1 and 3 months post-randomization.
Key facts
- Study ID
- NCT01237366
- Run by
- University of California, San Francisco
- People needed
- 56
- Starts
- 2010-09-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2014-10-27
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- 18 years of age or older
- Speak English
- Self-identify as a man who has sex with men
- Have been diagnosed with HIV for at least 3 months
- Provide evidence of HIV-positive serostatus
- Report using methamphetamine during the past 30 days
You may not qualify if…
- Do not have the capacity to provide informed consent
Where it is running
- UCSF Center for AIDS Prevention Studies — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.